Several noncanonical variants in MYO5B have been associated with low GGT cholestasis in recent years [4, 7, 14, 15]; meanwhile, some new potential pathogenic MYO5B noncanonical variants have also been clinically detected. Here, MYO5B is linked to cholestasis.